Yüklüyor......
Treatment of walking impairment in multiple sclerosis with dalfampridine
Potassium channel blockade has long been considered a potential therapeutic strategy for treatment of multiple sclerosis (MS) based on the pathophysiology of demyelinated axons. Dalfampridine, which is also known as fampridine or 4-aminopyridine (4-AP), is the potassium channel blocker that has been...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publications
2011
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3105618/ https://ncbi.nlm.nih.gov/pubmed/21694807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285611403960 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|